Congress responds to the IOM drug safety report--in full. [electronic resource]
Producer: 20071120Description: 2185-7 p. digitalISSN:- 1538-3598
- Clinical Trials as Topic -- legislation & jurisprudence
- Conflict of Interest
- Databases, Factual
- Drug Approval -- legislation & jurisprudence
- Drug-Related Side Effects and Adverse Reactions
- National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
- Politics
- Product Surveillance, Postmarketing
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.